Heparin-Induced Thrombocytopenia

被引：5
作者：
Nicolaides, A.
Fareed, J.
Kakkar, A. K.
Comerota, A. J.
Goldhaber, S. Z.
Hull, R.
Myers, K.
Samama, M.
Fletcher, J.
Kalodiki, E.
Bergqvist, D.
Bonnar, J.
Caprini, J. A.
Carter, C.
Conard, J.
Eklof, B.
Elalamy, I.
Gerotziafas, G.
Geroulakos, G.
Giannoukas, A.
Greer, I.
Griffin, M.
Kakkos, S.
Lassen, M. R.
Lowe, G. D. O.
Markel, A.
Prandoni, P.
Raskob, G.
Spyropoulos, A. C.
Turpie, A. G.
Walenga, J. M.
Warwick, D.
机构：
来源：
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 2013年 / 19卷 / 02期
关键词：
MOLECULAR-WEIGHT HEPARIN; PLATELET-AGGREGATION TEST; SEROTONIN-RELEASE ASSAY; CORONARY-ARTERY-BYPASS; OPTICAL-DENSITY VALUES; VENOUS LIMB GANGRENE; ARGATROBAN THERAPY; ANTIBODY-FORMATION; UNFRACTIONATED HEPARIN; HOSPITALIZED-PATIENTS;
D O I：
10.1177/1076029612474840s
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：208 / 214
页数：9
相关论文
共 117 条
[1]   Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies [J].
Ahmad, S ;
Haas, S ;
Hoppensteadt, DA ;
Lietz, H ;
Reid, U ;
Bender, N ;
Messmore, HL ;
Misselwitz, F ;
Bacher, P ;
Gaikwad, BS ;
Jeske, WP ;
Walenga, JM ;
Fareed, J .
THROMBOSIS RESEARCH, 2002, 108 (01) :49-55
[2]  
AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95
[3]   Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia [J].
Amiral, J ;
Wolf, M ;
Fischer, AM ;
BoyerNeumann, C ;
Vissac, AM ;
Meyer, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (04) :954-959
[4]   Heparin-induced thrombocytopenia and thrombosis [J].
Arepally, G ;
Cines, DB .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 1998, 16 (03) :237-247
[5]   Heparin-induced Thrombocytopenia Type II after Cardiac Surgery: Predictors and Outcome [J].
Assmann, A. ;
Boeken, U. ;
Feindt, P. ;
Schurr, P. ;
Akhyari, P. ;
Lichtenberg, A. .
THORACIC AND CARDIOVASCULAR SURGEON, 2010, 58 (08) :463-467
[6]   Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital [J].
Ban-Hoefen, Makiko ;
Francis, Charles .
THROMBOSIS RESEARCH, 2009, 124 (02) :189-192
[7]   Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: An analysis of outcomes in patients with elevated international normalized ratio (INR) [J].
Bartholomew, J ;
Hursting, M .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2005, 19 (03) :183-188
[8]   Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells [J].
Blank, M ;
Shoenfeld, Y ;
Tavor, S ;
Praprotnik, S ;
Boffa, MC ;
Weksler, B ;
Walenga, MJ ;
Amiral, J ;
Eldor, A .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (02) :121-129
[9]   A Randomized, Open-Label Pilot Study Comparing Desirudin and Argatroban in Patients With Suspected Heparin-Induced Thrombocytopenia With or Without Thrombosis: PREVENT-HIT Study [J].
Boyce, Steven W. ;
Bandyk, Dennis F. ;
Bartholomew, John R. ;
Frame, James N. ;
Rice, Lawrence .
AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (01) :14-22
[10]   Heparin-induced thrombocytopenia [J].
Brieger, DB ;
Mak, KH ;
Kottke-Marchant, K ;
Topol, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (07) :1449-1459
12345678910